Annals of Hepatology (Feb 2024)

BUN/creatinine ratio associated with mortality in patients with cirrhosis and acute kidney injury.

  • Diego F. Abendaño-Rivera,
  • Cristian Y Sánchez-Sánchez,
  • Karina Cazarin-Chávez,
  • Paloma M. Diego-Salazar,
  • Daniel Santana-Vargas,
  • María F. Higuera-De La Tijera,
  • José L. Pérez-Hernández

Journal volume & issue
Vol. 29
p. 101439

Abstract

Read online

Introduction and Objectives: Cirrhosis is a prevalent disease worldwide, with complications such as acute kidney injury (AKI) that increase the risk of fatal outcomes. A high BUN/creatinine ratio (IBC) has been associated with mortality in other diseases Therefore, evaluating this index in patients with cirrhosis could predict mortality. To determine whether a high BUN/creatinine ratio is associated with mortality in patients with cirrhosis and AKI. Materials and Patients: Retrospective analysis was conducted on a cohort of cirrhotic patients with and without AKI, calculating the IBC and assessing its association with mortality. Results: A total of 201 patients with cirrhosis were included, of whom 106 were male (52.73%), with a mean age of 55±10.4 years. The distribution of Child Pugh scores was as follows: A (25, 12.43%), B (70, 34.82%), and C (106, 52.73%); the mean MELD-Na score was 21.8±9.45. The cumulative mortality rate at 28 days was 37 (18.4%) and at 90 days was 39 (24.4%). The model was not significant at 28 days but was significant at 90 days with a X2 value of 48.18 (2) and p20 mg/dl vs. 20 mg/dl) could predict mortality in patients with cirrhosis, as the odds ratios at 28 and 90 days were significant.